HERBERT CRUZ: Open Payments
NPI 1023107513 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$56,836 in 127 payments from 12 companies in 2025. Trend: 2023 $60,481 · 2024 $81,226 · 2025 $56,836
Speaker / faculty: $41,639Consulting: $9,718Food & beverage: $3,242Travel & lodging: $2,014Education: $223
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 54 | $53,523 |
| E.R. Squibb & Sons, L.L.C. | 9 | $1,852 |
| Alkermes, Inc. | 28 | $577 |
| Teva Pharmaceuticals USA, Inc. | 5 | $264 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $227 |
| Axsome Therapeutics, Inc. | 3 | $144 |
| Lundbeck LLC | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Braeburn Inc. | 2 | $39 |
Products named: INGREZZA, ARISTADA, COBENFY, CAPLYTA, Auvelity, REXULTI, FANAPT, LYBALVI.
Industry payments across CA — which companies pay providers there.
